U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849622) titled 'Auto-antibody Dosage from Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease' on Feb. 20.
Brief Summary: Early diagnosis of type 1 diabetes and celiac disease is very useful, allows early therapy and prevents deaths from the onset of diabetic ketoacidosis. This is a pilot study on screening of autoantibodies of type 1 diabetes and celiac disease in tuscany patients. The study aims to evaluate the concordance between the screening results obtained using two different matrix (blood drop spots on card and serum) in the search for autoantibodies for celiac disease and for type 1 diabetes. Moreover, it will be evaluated the...